Stay updated on DC-806 in Plaque Psoriasis Clinical Trial
Sign up to get notified when there's something new on the DC-806 in Plaque Psoriasis Clinical Trial page.

Latest updates to the DC-806 in Plaque Psoriasis Clinical Trial page
- Check4 days agoChange DetectedThe completed Phase 2 DC-806 study record for moderate to severe plaque psoriasis is displayed, with details on trial arms, participant criteria, locations, outcome measures, and supporting documents.SummaryDifference73%

- Check11 days agoChange DetectedThe footer’s displayed site revision changed from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check25 days agoChange DetectedA site-wide NIH notice announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology, and the site revision number is updated to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe site footer revision identifier advances from v3.7.0 to v3.7.1, while the study page continues to show a 403 Forbidden error.SummaryDifference0.3%

- Check53 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the previous study record content. A minimal 403 page with a Home link is shown instead of the full content.SummaryDifference18%

- Check60 days agoChange DetectedThe page now displays the website revision as v3.7.0, replacing the previous v3.6.6. This update does not alter study details or visible content.SummaryDifference0.0%

Stay in the know with updates to DC-806 in Plaque Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DC-806 in Plaque Psoriasis Clinical Trial page.